Funding & tender opportunities
Innovative approaches to enhance
poverty-related diseases research
in sub-Saharan Africa
Dear colleagues, I would like to draw your attention in particular to the topic on «Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa» to continue cooperation investments in clinical research on infectious disease between the EU and sub-Saharan Africa after the last calls of the EDCTP2 programme until the Global Health EDCTP3 Joint Undertaking can launch its own calls.
Programme: Horizon Europe Framework Programme (HORIZON)
Call: Tackling diseases (2021) (HORIZON-HLTH-2021-DISEASE-04)
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions
Type of MGA: HORIZON Action Grant Budget-Based (HORIZON-AG)
Deadline model: single-stage
Opening date: 22 June 2021
Deadline date: 21 September 2021 17:00:00 Brussels time
Tackling diseases and reducing disease burden
Communicable and non-communicable diseases cause the greatest amounts of premature death and disability in the EU and worldwide. They pose a major health, societal and economic threat and burden. Many people are still suffering from these diseases and too often dying prematurely. Non-communicable diseases, including mental illnesses and neurodegenerative diseases, are responsible for up to 80% of EU health care costs [Currently, around 50 million people in the EU are estimated to suffer from two or more chronic conditions, and most of these people are over 65. Every day, 22 500 people die in Europe from those diseases, counting of 87% of all deaths. They account for 550 000 premature deaths of people of working age with an estimated €115 billion economic loss per year (0.8% of GDP).]. These costs are spent on the treatment of such diseases that, to a large extent, are preventable. Furthermore, only around 3% of the health care budgets are currently spent on preventive measures although there is a huge potential for prevention. Infectious diseases, including infections resistant to antimicrobials, remain a major threat to public health in the EU but also to global health security. Deaths caused by antimicrobial resistance (AMR) could exceed 10 million per year worldwide according to some predictions [AMR is estimated to be responsible for 25 000 deaths per year in the EU alone and 700 000 deaths per year globally. It has been estimated that AMR might cause more deaths than cancer by 2050.].